Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway.

European review for medical and pharmacological sciences - 1 Jan 2020

Zhao L-W, Yu A-J, Zhang Y-J, Wang X-C, Han B, Wang X-H

Abstract excerpt

OBJECTIVE: Ovarian cancer (OC) is one of the most lethal gynecologic malignant tumors. Emerging evidence has indicated that the dysregulation of microRNAs (miRNAs/miRs) participates in the OC progression. It has been revealed that miR-149 acts either as an oncogene or a tumour suppressor in various human tumors. The current study focused on the biological roles and potential mechanism of miR-149 in OC. PATIENTS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Down-Regulation
Share to MicroRNAs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Phenotype

Share to Phosphatidylinositol 3-Kinases

Share to Proto-Oncogene Proteins c-akt

Share to RNA-Binding Proteins

Source

Identifiers

PMID: 31957818
DOI: 10.26355/eurrev_202001_19895

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway.PMID 31957818Read ↗

CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulationSemantic proximity Read ↗

microRNA-324-3p suppresses the aggressive ovarian cancer by targeting WNK2/RAS pathwaySemantic proximity Read ↗

Five serum microRNAs for detection and predicting of ovarian cancerSemantic proximity Read ↗

Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-derived Ovarian Cancer Cells Compared With Primary Tumour TissueSemantic proximity Read ↗

CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.Semantic proximity Read ↗

The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancerSemantic proximity Read ↗

LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.Semantic proximity Read ↗

<p>Overview of microRNA-199a Regulation in Cancer</p>Semantic proximity Read ↗

MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.Semantic proximity Read ↗

MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinomaSemantic proximity Read ↗

Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expressionSemantic proximity Read ↗

PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.